Literature DB >> 31256709

A Single Injection of Docosahexaenoic Acid Induces a Pro-Resolving Lipid Mediator Profile in the Injured Tissue and a Long-Lasting Reduction in Neurological Deficit after Traumatic Brain Injury in Mice.

Orli Thau-Zuchman1, Rachael Ingram1, Georgina G Harvey1, Thomas Cooke1, Francesco Palmas2, Patrick N Pallier1, Joseph Brook3, John V Priestley1, Jesmond Dalli2, Jordi L Tremoleda1, Adina T Michael-Titus1.   

Abstract

Traumatic brain injury (TBI) can lead to life-changing neurological deficits, which reflect the fast-evolving secondary injury post-trauma. There is a need for acute protective interventions, and the aim of this study was to explore in an experimental TBI model the neuroprotective potential of a single bolus of a neuroactive omega-3 fatty acid, docosahexaenoic acid (DHA), administered in a time window feasible for emergency services. Adult mice received a controlled cortical impact injury (CCI) and neurological impairment was assessed with the modified Neurological Severity Score (mNSS) up to 28 days post-injury. DHA (500 nmol/kg) or saline were injected intravenously at 30 min post-injury. The lipid mediator profile was assessed in the injured hemisphere at 3 h post-CCI. After completion of behavioral tests and lesion assessment using magnetic resonance imaging, over 7 days or 28 days post-TBI, the tissue was analyzed by immunohistochemistry. The single DHA bolus significantly reduced the injury-induced neurological deficit and increased pro-resolving mediators in the injured brain. DHA significantly reduced lesion size, the microglia and astrocytic reaction, and oxidation, and decreased the accumulation of beta-amyloid precursor protein (APP), indicating a reduced axonal injury at 7 days post-TBI. DHA reduced the neurofilament light levels in plasma at 28 days. Therefore, an acute single bolus of DHA post-TBI, in a time window relevant for acute emergency intervention, can induce a long-lasting and significant improvement in neurological outcome, and this is accompanied by a marked upregulation of neuroprotective mediators, including the DHA-derived resolvins and protectins.

Entities:  

Keywords:  docosahexaenoic acid; functional improvement; lipid mediator profile; neuroprotection; traumatic brain injury

Mesh:

Substances:

Year:  2019        PMID: 31256709     DOI: 10.1089/neu.2019.6420

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  12 in total

1.  Acute injection of a DHA triglyceride emulsion after hypoxic-ischemic brain injury in mice increases both DHA and EPA levels in blood and brain.

Authors:  Denny Joseph Manual Kollareth; Richard J Deckelbaum; Zequn Liu; Rajasekhar Ramakrishnan; Charlotte Jouvene; Charles N Serhan; Vadim S Ten; Hylde Zirpoli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-09-25       Impact factor: 4.006

2.  Novel Approaches for Omega-3 Fatty Acid Therapeutics: Chronic Versus Acute Administration to Protect Heart, Brain, and Spinal Cord.

Authors:  Hylde Zirpoli; Chuchun L Chang; Yvon A Carpentier; Adina T Michael-Titus; Vadim S Ten; Richard J Deckelbaum
Journal:  Annu Rev Nutr       Date:  2020-09-23       Impact factor: 11.848

3.  A new ketogenic formulation improves functional outcome and reduces tissue loss following traumatic brain injury in adult mice.

Authors:  Orli Thau-Zuchman; Linda Svendsen; Simon C Dyall; Ursula Paredes-Esquivel; Molly Rhodes; John V Priestley; René G Feichtinger; Barbara Kofler; Susanne Lotstra; J Martin Verkuyl; Robert J Hageman; Laus M Broersen; Nick van Wijk; Jose P Silva; Jordi L Tremoleda; Adina T Michael-Titus
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 4.  Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine.

Authors:  Luca Cioccari; Nora Luethi; Mojgan Masoodi
Journal:  Front Immunol       Date:  2020-11-25       Impact factor: 7.561

5.  N-3 Polyunsaturated Fatty Acids Ameliorate Neurobehavioral Outcomes Post-Mild Traumatic Brain Injury in the Fat-1 Mouse Model.

Authors:  Jessica-Dominique Lecques; Brynna J K Kerr; Lyn M Hillyer; Jing X Kang; Lindsay E Robinson; David W L Ma
Journal:  Nutrients       Date:  2021-11-15       Impact factor: 5.717

Review 6.  Antioxidant Therapies in Traumatic Brain Injury.

Authors:  Valentina Di Pietro; Kamal M Yakoub; Giuseppe Caruso; Giacomo Lazzarino; Stefano Signoretti; Aron K Barbey; Barbara Tavazzi; Giuseppe Lazzarino; Antonio Belli; Angela Maria Amorini
Journal:  Antioxidants (Basel)       Date:  2020-03-22

7.  DHA Attenuates Cerebral Edema Following Traumatic Brain Injury via the Reduction in Blood-Brain Barrier Permeability.

Authors:  Zhuo-Hao Liu; Nan-Yu Chen; Po-Hsun Tu; Chen-Te Wu; Shao-Chieh Chiu; Ying-Cheng Huang; Siew-Na Lim; Ping K Yip
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

Review 8.  Microglial Metabolism After Pediatric Traumatic Brain Injury - Overlooked Bystanders or Active Participants?

Authors:  Aria C Shi; Ursula Rohlwink; Susanna Scafidi; Sujatha Kannan
Journal:  Front Neurol       Date:  2021-01-25       Impact factor: 4.003

Review 9.  Microglia: A Potential Drug Target for Traumatic Axonal Injury.

Authors:  Xin Huang; Wendong You; Yuanrun Zhu; Kangli Xu; Xiaofeng Yang; Liang Wen
Journal:  Neural Plast       Date:  2021-05-20       Impact factor: 3.599

10.  AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury.

Authors:  Hang Zhou; Libin Hu; Jianru Li; Wu Ruan; Yang Cao; Jianfeng Zhuang; Hangzhe Xu; Yucong Peng; Zhongyuan Zhang; Chaoran Xu; Qian Yu; Yin Li; Zhangqi Dou; Junwen Hu; Xinyan Wu; Xiaobo Yu; Chi Gu; Shenglong Cao; Feng Yan; Gao Chen
Journal:  J Neuroinflammation       Date:  2021-07-07       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.